Snippet from the article:
It’s being touted as the latest anticancer wonder drug, it costs just pennies a pill and is probably in your medicine cabinet right now.
A growing body of research is showing that people who take a daily dose of aspirin may be lowering their risk of a variety of seemingly unrelated cancers, including colon, breast, esophagus and skin cancer.
Now a study published this month in the Journal of the National Cancer Institute found that women who took a daily dose of aspirin cut their risk of ovarian cancer by as much as 20 percent.
That study, combined with earlier research, is prompting patients and doctors to wonder if more people would benefit from taking a low dose of aspirin and possibly other nonsteroid anti-inflammatory drugs.
Read the rest — Aspirin shows promise in lowering cancer risk